Exchange: NASDAQ·Updated 07:30 PM EDT
INM logo

INM InMed Pharmaceuticals Inc

$1.51
$0.025
(1.54%)
Today
Closed $1.60
$0.09
(5.63%)
After Hours
Reported EarningsMay 13
Mkt Cap$8.79M
Vol36,683.00

About INM

InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
70

Bullish Sentiment

How do you feel about INM?

skyrockets_Inc
$INM Three legacy assets up for sale. Latest PR states they 'continue to engage w/ potential parties to acquire or license'. Likely can fetch at least 5-10m minimum for all three or roughly $1-$2/share in CVR value. Free coupon IMO.
2
2
skyrockets_Inc
$INM CVR play. Merger vote happens November 6. "During the fiscal year, InMed continued to advance the development and transaction readiness of INM-901. The Company recently conducted a pre-Investigational New Drug (“IND”) meeting with the U.S. Food and Drug Administration (“FDA”) for the INM-901 program and is integrating FDA feedback into drug development planning. InMed also continues to engage with potential strategic parties regarding opportunities to acquire or license INM-901, INM-089 and/or INM-755."
1
4
skyrockets_Inc
$INM AI's take on the legacy assets value, remember that every 5.5m in asset sales equates to roughly $1/share in CVR value
1
1
i_like_bb_stock
$INM CVR record date is the close on 11/5 upon sale of legacy assets if u hold thru this date you'll receive 1 cvr for each share owned. once the assets are sold cash will be distributed based on the $$$ received from the assets
2

Advertisement|Remove ads.